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A cell-penetrating artiﬁcial metalloenzyme
regulates a gene switch in a designer mammalian
cell
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Stefan Matile4, Martin Fussenegger 2 & Thomas R. Ward1
Complementing enzymes in their native environment with either homogeneous or hetero-
geneous catalysts is challenging due to the sea of functionalities present within a cell. To
supplement these efforts, artiﬁcial metalloenzymes are drawing attention as they combine
attractive features of both homogeneous catalysts and enzymes. Herein we show that such
hybrid catalysts consisting of a metal cofactor, a cell-penetrating module, and a protein
scaffold are taken up into HEK-293T cells where they catalyze the uncaging of a hormone.
This bioorthogonal reaction causes the upregulation of a gene circuit, which in turn leads to
the expression of a nanoluc-luciferase. Relying on the biotin–streptavidin technology, varia-
tion of the biotinylated ruthenium complex: the biotinylated cell-penetrating poly(disulﬁde)
ratio can be combined with point mutations on streptavidin to optimize the catalytic uncaging
of an allyl-carbamate-protected thyroid hormone triiodothyronine. These results demonstrate
that artiﬁcial metalloenzymes offer highly modular tools to perform bioorthogonal catalysis in
live HEK cells.
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In recent years, there has been an increasing effort to exploitthe cell as a test-tube to complement the biochemical reactionnetworks with abiotic reactions1, 2 (Fig. 1a). With this goal in
mind, both organometallic complexes and nanoparticles have
been shown to catalyze abiotic reactions in Escherichia coli3–7,
mammalian cells8–21, and animals22–25. The outcome of such
intracellular abiotic reactions has been mostly limited to a
bioorthogonal output (i.e. uncaging of a ﬂuorescent molecule or
labeling of a protein) or a loss-of-function (i.e. drug-release that
leads to cell death)3–25. In a limited number of cases however, a
gain-of-function (productive modulation/activation of cellular
function) by an intracellular abiotic reaction has been
reported26, 27.
In addition to these efforts, metabolic engineering in E. coli,
yeast, and higher organisms has received increasing attention
thanks to its enormous potential to produce either high-added
value products and biofuels or to cure diseases28. In this latter
context, the assembly of gene switches allows for the construction
of engineered mammalian cells that are capable of sensing the
extracellular environment and producing output molecules on
demand (Fig. 1b)29–31. Thus far, only genetically encodable
modules have been integrated into designer mammalian cells.
This limits the available intracellular reaction repertoire to those
accessible from engineered natural enzymes.
Artiﬁcial metalloenzymes (ArMs hereafter), which result from
incorporation of an organometallic moiety within a protein
scaffold, combine attractive features of both homogeneous- and
enzymatic catalysts (Fig. 1c and Fig. 2)32, 33. Most recently, the
groups of Tezcan34 and Ward6 have demonstrated the possibility
to assemble and use ArMs in vivo in the periplasm of E. coli. As a
next step, we aim to integrate an ArM in a designed mammalian
cell to upregulate the expression of a reporter protein via a
complex reaction cascade (Fig. 1c). To achieve this goal, the
following challenges need to be addressed: (i) the efﬁcient uptake
of an ArM into mammalian cells; (ii) the assembly of a gene
switch that senses and responds to the product of the ArM
resulting in (iii) the intracellular upregulation of the gene switch
by the ArM.
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Fig. 1 Prior art and concept of the work. a A synthetic catalyst (metal complex or nanoparticle) converts A to A′ intracellularly (A′ is either a ﬂuorescent
probe or a drug). b A designer mammalian cell engineered with a synthetic gene circuit responds to an external trigger molecule B. c Introduction of ArMs
in designer cells for the control of a bioorthogonal reaction. The doubly caged molecule C is converted into C′ by an endogeneous natural enzyme. The
bioactive molecule C″, which upregulates a synthetic gene circuit, is produced by the ArM. All ﬁgures presented in this study were created by authors
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Fig. 2 Assembly of cell-penetrating ArMs. Ruthenium complexes 1 and 2 catalyze a bioorthogonal uncaging reaction. The biotinylated cell-penetrating poly
(disulﬁde) (CPD) bears a ﬂuorescent TAMRA moiety 5 allowing the monitoring of cellular uptake. Incorporation of both biotinylated moieties 2 and 5 in
various ratios (x and y) in tetrameric Sav affords a cell-permeable ArM for the uncaging of allyl carbamate-containing substrates within cells
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Herein we demonstrate the proof-of-principle of an intracel-
lular abiotic reaction enabled by an ArM modiﬁed with a cell-
penetrating module. This cell-penetrating ArM is taken up into
mammalian cells and catalyzes an abiotic reaction, leading to the
upregulation of a designed gene circuit.
Results
Design of a cell-penetrating artiﬁcial metalloenzyme. Thus far,
most of the reported intracellular abiotic catalysis has relied on
the catalysts’ inherent cell permeability: only few reports have
used cell-permeable carrier modules13, 16, 19, 20. In the absence of
a cell-permeable moiety, the efﬁciency of the catalyst’s cellular
uptake has been a matter of controversy14, 35. To achieve efﬁcient
delivery of an organometallic catalyst into cells, we capitalize on
the homotetrameric nature of a streptavidin scaffold to combine
an abiotic biotinylated catalyst with a biotinylated cell-penetrating
moiety. Additional attractive features of ArMs based on the
biotin–streptavidin technology include: (i) the possibility to
optimize the catalytic performance using genetic means6, 36 and
(ii) protection of the precious metal cofactor against detrimental
cellular components6, 37. We hypothesized that this Sav-based
approach to assemble a cell-permeable ArMs may provide a
versatile tool for the introduction of synthetic catalysts into cells.
With the aim of combining a gene switch with an abiotic
reaction catalyzed by an ArM in a designer mammalian cell, we
combined a ruthenium catalyst for the intracellular O-allyl
carbamate cleavage12, 14, 19, 35 with a gene switch that is
upregulated in the presence of the thyroid hormone, triiodothyr-
onine (T3)38. The T3 hormone is known to affect thermogenesis,
carbohydrate metabolism, and lipid homeostasis in all tissues.
Our T3-responsive gene switch has been shown to work in
various cell lines, including HEK-293T, Hela, immortalized
human mesenchymal stem cells (hMSC-TERT), HT-1080, and
CHO-K1 cells38. Among these cell lines, we selected HEK-293T
cells, which is the most responsive. Building on the ruthenium
complex 1 introduced by Meggers and co-workers14, the
biotinylated ruthenium complex 2 was prepared in situ by
mixing [CpRu(NCCH3)3](PF6) 3 and the biotinylated ligand 4 in
a 1:1 ratio. (Fig. 2). We selected the cell-penetrating poly
(disulﬁde) (CPD) 5, which was previously developed by us, as a
cell-permeable module (Fig. 2)39, 40. CPD is taken up via dynamic
covalent disulﬁde exchange with thiols on mammalian cell
surfaces. The presence of glutathione in the cytosol leads to
depolymerization of the CPD, thus alleviating continual
membrane-perturbing activities and reducing cytotoxicity com-
pared to traditional arginine-rich cell-penetrating peptides40, 41.
Relying on the versatility of the CPD as demonstrated for Hela
cells39 and Drosophila S2 cells40, we hypothesized that these
would be applicable for HEK-293T cells as well.
In vitro optimization of the ArM. To ensure efﬁcient coupling
between the reaction catalyzed by the ArM and the gene switch,
the performance of the ArM 22⊂ Sav (the subscript indicates the
number of biotinylated catalyst moieties 2 added to the homo-
tetrameric Sav) was optimized by single point mutations of the
Sav scaffold for the O-allyl carbamate cleavage of the caged
hormone (AT3) 6, to yield T3 7 (Fig. 3, Supplementary Figure 1).
The ruthenium complex 1 (ref.14) displayed higher activity than
both the biotinylated ruthenium complex 2 and the corre-
sponding ArM 22⊂ Sav wild type in vitro. Genetic optimization
of the catalytic performance of 22⊂ Sav was achieved by site-
directed mutagenesis at position Sav S112X or K121X, which are
the putative closest lying amino acid residues36. The mutant 22⊂
Sav S112A had a 2.5-fold higher TON (turnover number) than
the wild-type ArM and a comparable activity to the catalyst 1.
None of the screened double mutants outperformed 22⊂ Sav
S112A, which was selected for subsequent studies.
Designer cells with a T3-gene switch. In order to monitor the
output of the reaction cascade, which is reﬂected by the transgene
expression level resulting from the T3-gene switch, we slightly
adapted a previously reported thyroid hormone-responsive gene
switch in HEK-293T cells (Fig. 4a–c)38. This modiﬁed thyroid
hormone-responsive gene switch consists of a set of two plasmids,
pSP27 and pYO1. The plasmid pSP27 codes for a synthetic
thyroid hormone receptor (TSR), which is a fusion protein
comprised of the DNA-binding domain of yeast Gal4 and the T3-
binding domain of human thyroid receptor α (PhCMV-TSR-pA)
(PhCMV: human cytomegalovirus promoter). The plasmid pYO1
comprises a Gal4-speciﬁc operator sequence (PUAS5) connected to
a minimal hCMV promoter (PhCMVmin) that drives expression of
a secreted nanoluc (sec-nluc), a potent bioluminescence reporter
(PUAS5-sec-nluc-pA). In the absence of T3 7, TSR binds to PUAS5
and recruits endogenous corepressors, silencing mediators for
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Fig. 3 In vitro genetic optimization of the ArM. The ruthenium-catalyzed
uncaging of AT3 6 affords the thyroid hormone triiodothyronine T3 7.
Turnover numbers (TON) are based on yields of T3 7 determined by UPLC
with an internal standard. Experiments were performed at 37 °C for 16 h; 1,
2 (1 μM) or 22⊂ Sav (0.5 μM), AT3 6 (100 μM) in PBS (pH 7.5). Data are
the means ± standard deviation of duplicate reactions
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retinoid or thyroid hormone receptors (SMRT)/nuclear receptor
corepressor 2 (NcoR2), leading to histone deacetylation. As a
result, the expression of sec-nluc is repressed (Fig. 4b). In the
presence of T3 7, the TSR interaction with T3 recruits coactiva-
tors: steroid receptor coactivator 1 (SRC-1) and a 220-kDa
thyroid hormone receptor-associated protein complex compo-
nent (TRAP 220). These coactivators trigger histone acetylation
to initiate sec-nluc expression, which is monitored by the lumi-
nescent conversion of furimazine 9 into product 10 (Fig. 4a). As
an indicator of the cell viability, a human placental secreted
alkaline phosphatase (SEAP), was co-expressed constitutively by
pSEAP2-control (PSV40-SEAP-pA) (PSV40: similian virus 40
promoter). Hydrolysis of p-nitrophenylphosphate 11 affords p-
nitrophenolate 12, which can be monitored spectro-
photometrically at 405 nm (Fig. 4a–c).
Transport of native T3 7 into cells usually relies on a
transporter-mediated process42. As it was not clear whether the
AT3 6 is transported into cell via this pathway, we modiﬁed AT3 6
to increase its cell permeability. For this purpose, we esteriﬁed the
carboxylic group of AT3 6 with an acetoxymethyl (AM) group to
yield AM-AT3 8 (refs.43, 44). Upon passive diffusion of AM-AT3 8
into the cytosol, endogenous esterases rapidly hydrolyze it to
produce the allyl-carbamate protected AT3 6 (Fig. 4b, c).
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First, we investigated the dose-dependence of T3 7 and AM-
AT3 8 against the T3-responsive gene switch (pSP27 and pYO1)
and the pSEAP-2 control (Supplementary Figure 2). When using
T3 7, the luminescence intensity derived from the expressed sec-
nluc activity reached a plateau at very high gene expression level
(i.e. >6 nM T3 7). At concentrations below 500 nM, AM-AT3 8
did not induce sec-nluc expression. This highlights the efﬁcient
caging effect of the allyl carbamate moiety of AM-AT3 8.
Gratifyingly, the phosphatase activity of SEAP did not decrease in
the presence of AM-AT3 8: we thus conclude that it does not
exhibit cytotoxicity at these concentrations.
Intracellular abiotic reaction. After the in vitro identiﬁcation of
the most active ArM for the allyl-carbamate cleavage of AT3 6
(see Fig. 3), we next assembled a cell-penetrating ArM 2x5y⊂ Sav
S112A by sequential incorporation of the ruthenium complex 2
and biotinylated CPD 5 into Sav S112A (Fig. 2, Supplementary
Figure 3 and Supplementary Discussion). Capitalizing on the four
biotin-binding sites present in Sav, the ratio of the ruthenium
catalyst 2 and CPD 5 was optimized. Based on a previous report40
and a preliminary screening experiment (Supplementary Fig-
ure 4), the concentrations of CPD 5 and AM-AT3 8 were set to
0.5 and 4 μM, respectively. These concentrations were selected to
maximize the cellular uptake of the ArM with the minimum cell
toxicity and minimize the background luminescence caused by
AM-AT3 8.
The designer HEK-293T cells transfected with the T3-
responsive gene switch were treated with ArM 2x5y⊂ Sav
S112A. Following incubation and careful washing of the cells to
remove surface-adsorbed ArM, the substrate AM-AT3 7 (4 μM)
was added (Fig. 4a). We monitored the ArM’s uptake in the
designer cell by the confocal microscopy (Supplementary
Figure 5) and ﬂow cytometry (Fig. 4d) before and after the
reaction respectively. For comparison, the CPD 5 was replaced by
Atto565-Biotin, which exhibits similar spectroscopic features to
CPD 5 but is not internalized by covalent-mediated translocation
through the cell-membrane (Supplementary Figure 6 and
Supplementary Discussion), to afford 21(Atto565-Biotin)1⊂ Sav.
In the case of 21(Atto565-Biotin)1⊂ Sav, the ﬂuorescence derived
from Atto565-Biotin was not detectable either by confocal
microscopy or ﬂow cytometry. This indicates that the ArM
devoid of CPD 5 is not cell-permeable. In contrast, the cellular
uptake of ArMs 2x5y⊂ Sav was conﬁrmed by the pronounced
increase in ﬂuorescence within the cells caused by the presence of
TAMRA moieties on the ArMs.
As for the intracellular reactions, the luminescence intensities
resulting from the induced sec-nluc activity were markedly higher
in the presence of the ArM 2151⊂ Sav S112A than with model
catalyst 1 (Fig. 4e). Although its activity in vitro is comparable to
that of the ArM 22⊂ Sav S112A (Fig. 3), the use of complex 1 did
not lead to higher luminescence intensities than when the
designer cells were treated with the substrate AM-AT3 8 but in
the absence of any Ru-catalyst (Fig. 4e). The cofactor 2 alone and
the ArM 21⊂ Sav S112A were also examined and found not to
turn on the gene switch (Supplementary Figure 7 and
Supplementary Discussion). This corroborates the ﬂow cytometry
observations, highlighting the limited uptake in HEK-293T cells
when low Ru-concentrations are used (e.g. <1.5 μM)35. These
results conﬁrm that only cell-penetrating ArMs turn on the T3-
responsive gene switch by producing T3 7 via the intracellular
uncaging of AT3 6. Increasing the Ru-catalyst 2 to CPD 5 ratio
led to higher luminescence intensities: the highest activity was
observed with the ArM 2351⊂ Sav S112A. This highlights the
importance of the “membrane permeability” and the “inter-
nalization” features of the cell-penetrating ArM. The cell viability,
reﬂected by the SEAP activity, is essentially constant for all
conditions tested. This conﬁrms that there is no critical
cytotoxicity for the intracellular reaction cascade (Fig. 4f).
Discussion
Herein, we have demonstrated the versatility of a complex
intracellular reaction cascade that results from combining a cell-
penetrating ArM with a synthetic gene circuit. The uncaging
reaction catalyzed by the ArM leads to the exquisite control of a
designer cell, ultimately upregulating the activity of a genetically
encoded sec-nluc. The observed output of this system is unam-
biguous. However, further improvement would be desirable for
practical use. For this purpose, in vivo directed evolution of ArMs
have proven versatile6. Also, it may be possible to stably integrate
the gene switch into designer cells to allow for the selection of the
best performing single cell clone45.
Although cell-targeting modules have previously been com-
bined with organometallic moieties to catalyze intracellular
transformations19, the use of a Sav-based ArM combines several
attractive features including: (i) a straightforward means to
assemble and optimize the ArMs by chemical and genetic stra-
tegies, (ii) easy modulation of the catalyst:CPD ratio to ﬁne-tune
the uptake and the activity of the ArM, (iii) a means to visualize
by ﬂuorescence the internalization of the ArM, and (iv) the
shielding of the precious metal moiety within a protein scaffold37.
This proof-of-concept highlights the gain of cellular function
that critically relies on a reaction requiring components that are
not genetically encoded. This strategy may be extended to new-
to-nature reactions based on related ArMs: Suzuki-coupling,
metathesis and C–H activation33. This may allow to endow
mammalian cells with highly versatile catalytic function. We thus
Fig. 4 An ArM-catalyzed intracellular reaction induces a gene switch. a Following seeding and incubation (43 h), the HEK-293T cells (approx. 5 × 106 cells/
10 cm dishes) were transfected with pSP27 (PhCMV-TSR-pA), pYO (PUAS5-sec-nluc-pA), and pSEAP2-control (PSV40-SEAP-pA). The resulting transfected
cells were dispensed into a collagen-coated 24-well cell culture plate with two times diluted concentration and incubated overnight. Cells were treated with
either the ruthenium complex 1 or the ArM 2x5y⊂ Sav S112A (0.17–1.5 μM ruthenium). After 1 h, the cells were washed and subsequently incubated with
AM-AT3 8 (4 μM, 24 h). Activities of the sec-nluc (luminescent conversion of 9 into 10) and SEAP (conversion of 11 into chromophore 12) were quantiﬁed
using the supernatant of the cell culture medium. b A designer cell in the absence of ArM 2x5y⊂ Sav S112A. In the absence of T3 7, TSR associates with
corepressors (SMRT/NcoR2) on the PUAS5 and deacetylation of histone is triggered thus inhibiting gene expression. c The designer cell including the ArM
2x5y⊂ Sav S112A. AM-AT3 8 is sequentially converted into AT3 6 and T3 7 by endogenous esterases and the ArM respectively. TSR bound to T3 7 interacts
with coactivators (SRC-1, TRAP 220) on the PUAS5 to trigger histone acetylation, resulting in gene expression. In both b and c, SEAP is continuously
expressed: its phosphatase activity against p-nitrophenylphosphate 11 allows to estimate the cell viability. d The uptake of ArMs revealed by the
ﬂuorescence from either the biotinylated TAMRA- or the Atto565-moieties. After 24 h incubation with AM-AT3 8, cells were analyzed by ﬂow cytometry
(ex. 561 nm, em. 586 ± 15 nm band-pass). As a control experiment, Atto565-biotin was used instead of CPD 5. Quantiﬁcation of the enzymatic activities of
e the expressed sec-nluc induced by the uncaging activity of ArM 2x5y⊂ Sav S112A (green), the Ru-complex 1 (beige), or without a catalyst (gray) and f the
constitutively expressed SEAP after 24 h. The ratio of biotinylated catalyst 2 and CPD 5 added to the tetrameric Sav scaffold is described as (x, y). Data
displayed are the means ± standard deviation of experiments performed in triplicate
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believe that this study may offer a novel means to engineer cel-
lular function via highly modular cell-penetrating ArMs.
Methods
Synthesis of chemical compounds. Details are collected in the Supplementary
Information (Supplementary Figures 8–17 and Supplementary Methods)
Stock solutions of Sav, 1, 2, ArM 2x⊂ Sav, and ArM 2x5y⊂ Sav. Sav-stock
solutions (stock A) were prepared in phosphate-buffered saline (PBS) (pH 7.5) or
water to yield 800 μM free biotin-binding site (referred to as FBBS). A stock
solution (stock B) of the ruthenium complex 1 (2 mM) was prepared in dimethyl
sulfoxide (DMSO). A stock solution (stock C) of the ruthenium complex 2 (5 mM)
was prepared by mixing [CpRu(NCCH3)3](PF6) 3 (10 mM in DMF) and the bio-
tinylated ligand 4 (Supplementary Figure 9) (10 mM in DMF) in a 1:1 ratio. These
stock solutions were freshly prepared for each experiment. The ArM 2x ⊂ Sav was
prepared using the conditions listed in Supplementary Tables 1–3, respectively.
Stock C was incubated with water for 10 min prior to the addition of stock A. The
ArM 2x5y ⊂ Sav was prepared using the conditions collected in Supplementary
Tables 4–9. After mixing the ArM 2x ⊂ Sav and water, CPD 5 was added and
incubated for 2 h.
Screening Sav for the uncaging of AT3 6. Prior to Sav mutant screening,
potassium isocyanoacetate was tested as an irreversible inhibitor for the catalytic
activity of the ruthenium complexes 1, 2 and ArM 22⊂ Sav (see Fig. 3 and Sup-
plementary Figure 1). Allyl carbamate caged amino-coumarin 13 (see Supple-
mentary Figure 18a) was used as a substrate. The reaction conditions are collected
in Supplementary Table 10. Experiments were performed at 37 °C in a 96-well
plate. The ﬂuorescence intensity at 450 nm derived from the produced 7-amino-4-
methylcoumarin 14 (excitation at 375 nm) was monitored with a Tecan Inﬁnite
M1000 Pro (Supplementary Figure 18b). Potassium isocyanoacetate was found to
efﬁciently inhibit the catalytic activity of ruthenium complexes 1, 2 and ArM 22⊂
Sav. Based on this, potassium isocyanoacetate was added to the reaction mixture to
quench the reaction during the genetic optimization of the ArM’s activity. For the
screening of Sav variants, AT3 6 was used as a substrate. Reaction conditions are
listed in Supplementary Table 11 and were performed at 37 °C in an HPLC vial.
Potassium isocyanoacetate (500mM in water, 4 μL), tryptophanamide hydro-
chloride (10mM in water, 20μL) as an internal standard, acetonitrile (800μL), and
PBS (400 μL) were added to the reaction mixture. The resulting solution was
centrifuged (10,000g) and analyzed by UPLC-MS (Supplementary Figure 19).
TONs were determined based on the calibration curve of T3 7 (Supplementary
Figure 20).
Cell culture and transfection. The following three-cell culture media were pre-
pared: medium A [Dulbecco’s modiﬁed eagle medium (DMEM; Invitrogen) con-
taining 10% (v/v) fetal bovine serum (FBS; Sigma-Aldrich), 1% (v/v) penicillin/
streptomycin (PS) solution (Sigma-Aldrich)], medium B [DMEM containing 1%
(v/v) PS], medium C [DMEM containing 5% (v/v) charcoal stripped FBS (Gibco),
1% (v/v) PS]
Daily cell culture: HEK-293T cells (DSMZ: ACC-635) were cultivated in
medium A at 37 °C in a humidiﬁed atmosphere containing 5% CO2. For serial
passage of these cells, 0.05% Trypsin-EDTA (Gibco) was used. For HEK-293T cells
which we used in this paper, microplasma (−) is guaranteed by the supplier
(Online methods, cell culture, and transfection section) (https://www.dsmz.de/
catalogues/details/culture/ACC305.html?tx_dsmzresources_pi5%5BreturnPid%5D
= 192). Also, we exclusively use cells that are regularly checked for bacterial
contamination.
Transfection (Supplementary Table 12): In 10 cm dishes, 1.25 × 105/mL of
HEK-293T cells were seeded and cultivated in medium A at 37 °C in a humidiﬁed
atmosphere containing 5% CO2 during 43 h prior to transfection. To prepare the
transfection mix, 19.2 μL of pSP27 (69.9 ng/μL, 1300 ng), 12.5 μL of pYO1 (641 ng/
μL, 7800 ng), and 1.7 μL of pSEAP2-control (561 ng/μL, 900 ng) were added to 1
mL of medium B. The resulting solution was mixed with 50 μL of polyethylenimine
(PEI, 20000 MW, Polysciences; stock solution 1 mg/mL in dH2O) and incubated
for 15 min at ambient temperature. At least 30 min before addition of the prepared
DNA-PEI mixture (1 mL) to the cells, the cell culture medium A was replaced by
medium C. After 8 h incubation, the cell culture medium was replaced with fresh
medium C. The transfected cells were split into a collagen-coated 24-well cell
culture plate with a two times diluted concentration and cultivated overnight. The
resulting 24-well plates were used for subsequent experiments.
Intracellular catalysis of ArM 2x5y⊂ Sav and FACS analysis. ArMs 2x5y⊂ Sav
(Supplementary Tables 4–9) were diluted by a factor 50 with medium B. A stock of
the ruthenium complex 1 (2 mM in DMSO) was also diluted with medium B to
0.17–2.0 μM. The cell culture medium C of the aforementioned 24-well plate with
the designer HEK-293T cells was replaced by media B containing either ArM
2x5y⊂ Sav or ruthenium complex 1. After 1 h incubation, the cells were washed
three times with medium B containing heparin (0.1 mg/mL) to remove cell-
surface-adsorbed ArM 2x5y⊂ Sav as previously reported46. The washed cells were
incubated in the medium C containing AM-AT3 8 (4 μM) with 0.5% DMSO for 24
h. Expression of sec-nluc and SEAP was quantiﬁed in the supernatant as described
in the following section. Then, cells were detached using 0.05% trypsin-EDTA. The
cell populations were analyzed using a Becton Dickinson LSRII Fortessa Flow
Cytometer (Becton Dickinson) (conditions: ﬁlter set for monitoring red ﬂuores-
cence; 561-nm laser, mirror: 570 LP, Filter: 586/15 BP). Data were analyzed by
FlowJo. Populations of living cells (23963 to 25336 events) were extracted from
30,000 events based on SSC and FSC.
Activity assays of SEAP and sec-nluc. SEAP: The supernatant was transferred
into a 96-well plate (100 μL/well) and incubated at 65 °C for 30 min to heat-
inactivate endogenous alkaline phosphatases. After cooling, 80 μL of the treated
supernatant was mixed with 100 μL of 2× SEAP buffer (20 mM homoarginine, 1
mM MgCl2, 21% (v/v) diethanolamine, pH 9.8) and 20 μL of 720 μM of p-nitro-
phenylphosphate. Immediately thereafter, the absorbance was measured at 405 nm
at 37 °C using the EnVision 2104 Multilabel Reader. The measurement was per-
formed over 61 repeats of 30 s/repeat and the plate was shaken for 5 s at 900 rpm at
the beginning. From the time-course increase of the absorbance at 405 nm, derived
from the enzymatic activity of SEAP, the activity of SEAP (in U/L) was determined.
To avoid saturation effects, the linear part of the time-course plots was used for the
determination of the slope. The correlation between the slope and the corre-
sponding activity was determined using a standard.
Sec-nluc: The supernatant was transferred into a black 384-well plate (7.5 µL/
well), and the same amount of nanoglo assay solution (Promega). After 5 min
incubation, the luminescence was measured with Tecan Inﬁnite M1000 Pro.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available either in the paper and in the Supplementary Information or
from the authors upon reasonable request.
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